Friday, March 24, 2017 3:32:08 AM
BY PHILLIP BROADWITH23 MARCH 2017 Firms spar over single-molecule gene sequencing technology
Gene sequencing firm Pacific Biosciences is suing rival Oxford Nanopore Technologies for patent infringement, after successfully filing a broad patent on nanopore sequencing technology.
PacBio claims that Oxford Nanopore’s MinIon and PromethIon sequencers – which use protein-based pores to electronically read nucleic acid sequences – infringe US patent 9546400, granted to PacBio in January 2017. PacBio’s own sequencers employ its Single Molecule Real Time (SMRT) sequencing technology, in which sequences are determined by synthesising complementary DNA strands inside nanosized ‘waveguide’ wells.
‘We believe this is another frivolous lawsuit brought by a competitor nervous about our superior technology,’ said Oxford Nanopore’s chief executive, Gordon Sanghera in a statement. The company was sued for patent infringement by sequencing heavyweight Illumina in 2016, but settled the dispute by switching to a different pore protein.
https://www.chemistryworld.com/news/pacbio-sues-oxford-nanopore-for-patent-infringement/3007010.article
Recent PACB News
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:54:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:52:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 10:06:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:07:28 PM
- PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results • PR Newswire (US) • 02/15/2024 09:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM